Literature DB >> 1705876

Interleukin-6 is a major myeloma cell growth factor in vitro and in vivo especially in patients with terminal disease.

B Klein1, X G Zhang, M Jourdan, M Portier, R Bataille.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1705876     DOI： 10.1007/978-3-642-75889-8_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  3 in total

Review 1.  Age-associated chronic diseases require age-old medicine: role of chronic inflammation.

Authors:  Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Prev Med       Date:  2011-12-09       Impact factor: 4.018

Review 2.  The treatment of multiple myeloma--an important MRC trial.

Authors:  P W Johnson; P J Selby
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

3.  Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells.

Authors:  M Amit-Vazina; S Shishodia; D Harris; Q Van; M Wang; D Weber; R Alexanian; M Talpaz; B B Aggarwal; Z Estrov
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.